Mangalam Drugs & Organics Limited
NSE: MANGALAM.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Govardhan Murlidhar Dhoot
- Employees
- 432
- Headquarters
- Mumbai, India
- IPO year
- 2005
- Market cap
- ₹479.9M
- Website
- https://www.mangalamdrugs.com
Loading MANGALAM…
Loading profile data…Frequently asked questions about MANGALAM
What does Mangalam Drugs & Organics Limited (MANGALAM.NS) do?
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applicatio...
Where does MANGALAM.NS trade?
Mangalam Drugs & Organics Limited (MANGALAM.NS) trades on the National Stock Exchange of India.
What sector is MANGALAM.NS in?
Mangalam Drugs & Organics Limited (MANGALAM.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Mangalam Drugs & Organics Limited?
Govardhan Murlidhar Dhoot is the chief executive officer of Mangalam Drugs & Organics Limited (MANGALAM.NS).
Where is Mangalam Drugs & Organics Limited headquartered?
Mangalam Drugs & Organics Limited is headquartered in India.
Does MANGALAM.NS pay a dividend?
Mangalam Drugs & Organics Limited (MANGALAM.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MANGALAM.NS go public?
Mangalam Drugs & Organics Limited (MANGALAM.NS) completed its initial public offering in 2005.